Chen M - Search Results

1

Therapeutic targeting of PLK1 in TERT promoter-mutant hepatocellular carcinoma.

Tang Q, Hu G, Sang Y, Chen Y, Wei G, Zhu M, Chen M, Li S, Liu R, Peng Z. Tang Q, et al. Among authors: chen m, chen y. Clin Transl Med. 2024 May;14(5):e1703. doi: 10.1002/ctm2.1703. Clin Transl Med. 2024. PMID: 38769666 Free PMC article.

2

The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations.

Xue J, Li S, Shi P, Chen M, Yu S, Hong S, Li Y, Liu R, Xiao H. Xue J, et al. Among authors: chen m. Front Oncol. 2021 Jun 16;11:649323. doi: 10.3389/fonc.2021.649323. eCollection 2021. Front Oncol. 2021. PMID: 34221969 Free PMC article.

3

Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer.

Chen M, Xue J, Sang Y, Jiang W, He W, Hong S, Lv W, Xiao H, Liu R. Chen M, et al. BMC Cancer. 2023 Apr 20;23(1):363. doi: 10.1186/s12885-023-10852-z. BMC Cancer. 2023. PMID: 37081420 Free PMC article.

4

The activation of mTOR signalling modulates DNA methylation by enhancing DNMT1 translation in hepatocellular carcinoma.

Chen M, Fang Y, Liang M, Zhang N, Zhang X, Xu L, Ren X, Zhang Q, Zhou Y, Peng S, Yu J, Zeng J, Li X. Chen M, et al. J Transl Med. 2023 Apr 23;21(1):276. doi: 10.1186/s12967-023-04103-9. J Transl Med. 2023. PMID: 37088830 Free PMC article.

5

Methylation-Mediated Silencing of ATF3 Promotes Thyroid Cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.

Xiao X, Chen M, Sang Y, Xue J, Jiang K, Chen Y, Zhang L, Yu S, Lv W, Li Y, Liu R, Xiao H. Xiao X, et al. Among authors: chen m, chen y. Thyroid. 2023 Dec;33(12):1441-1454. doi: 10.1089/thy.2023.0157. Epub 2023 Oct 27. Thyroid. 2023. PMID: 37742107

6

Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer.

Sang Y, Hu G, Xue J, Chen M, Hong S, Liu R. Sang Y, et al. Among authors: chen m. Endocrine. 2024 Jul;85(1):304-312. doi: 10.1007/s12020-024-03722-6. Epub 2024 Feb 14. Endocrine. 2024. PMID: 38356100

7

The ERK inhibitor GDC-0994 selectively inhibits growth of BRAF mutant cancer cells.

Chen Y, Sang Y, Li S, Xue J, Chen M, Hong S, Lv W, Sehgal K, Xiao H, Liu R. Chen Y, et al. Among authors: chen m. Transl Oncol. 2024 Jul;45:101991. doi: 10.1016/j.tranon.2024.101991. Epub 2024 May 9. Transl Oncol. 2024. PMID: 38728872 Free PMC article.

8

MT1G is Silenced by DNA Methylation and Contributes to the Pathogenesis of Hepatocellular Carcinoma.

Zeng JD, Zhang N, Zhao GJ, Xu LX, Yang Y, Xu XY, Chen MK, Wang HY, Zheng SX, Li XX. Zeng JD, et al. J Cancer. 2018 Jul 16;9(16):2807-2816. doi: 10.7150/jca.25680. eCollection 2018. J Cancer. 2018. PMID: 30123349 Free PMC article.

9

Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes.

Cao D, Chen MK, Zhang QF, Zhou YF, Zhang MY, Mai SJ, Zhang YJ, Chen MS, Li XX, Wang HY. Cao D, et al. Aging (Albany NY). 2020 Jun 16;12(12):12187-12205. doi: 10.18632/aging.103395. Epub 2020 Jun 16. Aging (Albany NY). 2020. PMID: 32544882 Free PMC article.

10

RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma.

Wang X, Chen M, Liang X, Bai Y, Zeng J, Xu X, Li H, Wang J, Fan K, Zhao G. Wang X, et al. Among authors: chen m. Front Oncol. 2022 Jan 25;11:752511. doi: 10.3389/fonc.2021.752511. eCollection 2021. Front Oncol. 2022. PMID: 35145901 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51,463 results

Search Page

Filters